ID: ALA4175749

Max Phase: Preclinical

Molecular Formula: C51H62N8O5

Molecular Weight: 867.11

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCn1cc(C[C@@H](NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](Cc2ccccc2)NC)C(=O)N[C@@H](CC(C)C)C(N)=O)c2ccccc21

Standard InChI:  InChI=1S/C51H62N8O5/c1-5-6-25-59-32-37(39-22-14-16-24-46(39)59)30-45(50(63)55-41(47(52)60)26-33(2)3)58-49(62)43(28-35-19-11-8-12-20-35)56-51(64)44(29-36-31-54-40-23-15-13-21-38(36)40)57-48(61)42(53-4)27-34-17-9-7-10-18-34/h7-24,31-33,41-45,53-54H,5-6,25-30H2,1-4H3,(H2,52,60)(H,55,63)(H,56,64)(H,57,61)(H,58,62)/t41-,42+,43-,44+,45+/m0/s1

Standard InChI Key:  NUTKRFLCOCQKQW-JXXGGQSTSA-N

Associated Targets(Human)

NCI-H69 709 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

DMS-79 150 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 867.11Molecular Weight (Monoisotopic): 866.4843AlogP: 5.25#Rotatable Bonds: 23
Polar Surface Area: 192.24Molecular Species: NEUTRALHBA: 7HBD: 7
#RO5 Violations: 3HBA (Lipinski): 13HBD (Lipinski): 8#RO5 Violations (Lipinski): 4
CX Acidic pKa: 11.94CX Basic pKa: 8.34CX LogP: 6.53CX LogD: 5.54
Aromatic Rings: 6Heavy Atoms: 64QED Weighted: 0.05Np Likeness Score: -0.19

References

1. Haitham Abusara O, Freeman S, Aojula HS..  (2017)  Pentapeptides for the treatment of small cell lung cancer: Optimisation by Nind-alkyl modification of the tryptophan side chain.,  137  [PMID:28595067] [10.1016/j.ejmech.2017.05.053]

Source